Manufacturers Life Insurance Company, The Fibrogen Inc Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$0.73 - $2.73 $22,079 - $82,571	30,246 New	30,246 $71,000
Q2 2023 Aug 11, 2023	SELL	$2.49 - $20.59 $100,663 - $832,391	-40,427 Reduced 52.29%	36,880 $99,000
Q1 2023 May 15, 2023	SELL	$15.95 - $25.18 $322,652 - $509,366	-20,229 Reduced 26.17%	57,078 $1.07 Million
Q4 2022 Aug 11, 2023	BUY	$13.27 - $17.73 $556,384 - $743,383	41,928 Added 118.51%	77,307 $1.24 Million
Q4 2022 Feb 13, 2023	BUY	$13.27 - $17.73 $556,384 - $743,383	41,928 Added 118.51%	77,307 $1.24 Million
Q3 2022 Aug 11, 2023	SELL	$11.4 - $14.6 $9,439 - $12,088	-828 Reduced 2.29%	35,379 $460,000
Q3 2022 Nov 03, 2022	SELL	$11.4 - $14.6 $9,439 - $12,088	-828 Reduced 2.29%	35,379 $460,000
Q2 2022 Aug 11, 2023	SELL	$7.94 - $12.96 $1,746 - $2,851	-220 Reduced 0.6%	36,207 $382,000
Q2 2022 Aug 15, 2022	SELL	$7.94 - $12.96 $1,746 - $2,851	-220 Reduced 0.6%	36,207 $382,000
Q1 2022 Aug 11, 2023	SELL	$12.02 - $16.79 $248,225 - $346,730	-20,651 Reduced 36.18%	36,427 $437,000
Q1 2022 May 20, 2022	SELL	$12.02 - $16.79 $101,508 - $141,791	-8,445 Reduced 18.82%	36,427 $438,000
Q4 2021 Feb 16, 2022	SELL	$9.93 - $15.39 $10,615 - $16,451	-1,069 Reduced 2.33%	44,872 $633,000
Q3 2021 Nov 12, 2021	SELL	$10.18 - $26.64 $28,707 - $75,124	-2,820 Reduced 5.78%	45,941 $470,000
Q2 2021 Aug 12, 2021	BUY	$18.57 - $35.68 $21,596 - $41,495	1,163 Added 2.44%	48,761 $1.3 Million
Q1 2021 May 03, 2021	SELL	$31.0 - $55.72 $89,776 - $161,365	-2,896 Reduced 5.74%	47,598 $1.65 Million
Q4 2020 Feb 12, 2021	BUY	$37.09 - $48.97 $67,095 - $88,586	1,809 Added 3.72%	50,494 $1.87 Million
Q3 2020 Nov 09, 2020	SELL	$40.47 - $45.5 $31,607 - $35,535	-781 Reduced 1.58%	48,685 $2 Million
Q2 2020 Aug 10, 2020	SELL	$32.57 - $42.83 $16,252 - $21,372	-499 Reduced 1.0%	49,466 $2.01 Million
Q1 2020 May 15, 2020	BUY	$23.3 - $45.96 $76,191 - $150,289	3,270 Added 7.0%	49,965 $1.74 Million
Q4 2019 Feb 14, 2020	SELL	$34.58 - $48.06 $49,103 - $68,245	-1,420 Reduced 2.95%	46,695 $2 Million
Q3 2019 Nov 12, 2019	SELL	$36.98 - $48.45 $12,610 - $16,521	-341 Reduced 0.7%	48,115 $1.82 Million
Q2 2019 Aug 14, 2019	SELL	$35.13 - $55.53 $46,231 - $73,077	-1,316 Reduced 2.64%	48,456 $2.19 Million
Q1 2019 May 13, 2019	SELL	$42.83 - $59.91 $74,695 - $104,483	-1,744 Reduced 3.39%	49,772 $2.71 Million
Q4 2018 Feb 14, 2019	BUY	$37.97 - $60.16 $111,479 - $176,629	2,936 Added 6.04%	51,516 $2.38 Million
Q3 2018 Nov 14, 2018	SELL	$56.3 - $67.25 $383,515 - $458,107	-6,812 Reduced 12.3%	48,580 $2.95 Million
Q2 2018 Aug 14, 2018	BUY	$44.9 - $64.95 $150,908 - $218,296	3,361 Added 6.46%	55,392 $3.47 Million
Q1 2018 May 15, 2018	SELL	$45.35 - $61.65 $52,878 - $71,883	-1,166 Reduced 2.19%	52,031 $2.4 Million
Q4 2017 Feb 08, 2018	BUY	$41.95 - $60.1 $120,480 - $172,607	2,872 Added 5.71%	53,197 $2.52 Million
Q3 2017 Nov 14, 2017	BUY	$33.4 - $53.9 $1.68 Million - $2.71 Million	50,325	50,325 $2.71 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account